Abstract
BACKGROUND AND PURPOSE: Cocaine and its metabolites can produce vasospasm, and cocaine-dependent patients are at increased risk for stroke. Based on previous case reports, we hypothesized that the incidence of hyperintense brain lesions observed on T2-weighted MR images would also be increased in asymptomatic cocaine-dependent individuals.
METHODS: Sixty-two male “crack” (smoked) cocaine–dependent participants ranging in age from 25 to 66 years were compared with 116 normal male control participants ranging in age from 25 to 80 years. Those with histories of neurologic symptoms or illnesses were excluded. The severity of hyperintense lesions was rated on a 0- to 3-point scale, and ratings of 3 were used in the data analysis as an indicator of a probable pathologic process. Three regions were separately rated: the cerebral white matter, insular subcortex white matter, and subcortical gray matter (basal ganglia and thalamus region).
RESULTS: Significantly increased risk of severe lesions was observed in the two white matter regions of the cocaine-dependent group (odds ratio of 16.7 and 20.3) but not in the subcortial gray matter region (odds ratio of 1.4). In the insula subcortex white matter, the risk of lesions increased with age in the cocaine-dependant sample, but remained essentially absent among normal controls through the age of 80 years. In the cerebral white matter, the relationship of age and risk of lesion among normal participants was similar in shape to that in cocaine-dependent participants, but equivalent risk was seen 20 years earlier among cocaine-dependent participants.
CONCLUSIONS: Cocaine-dependent participants had a significantly increased age-related risk of white matter damage. The possible clinical implications of this damage are discussed.
Cocaine dependence is associated with vascular events and is a common cause of clinically apparent stroke in young individuals, even in the absence of other risk factors (1–6). Vasospasm induced by cocaine and its metabolites (7, 8), with or without secondary intravascular thrombosis (9), is thought to be the principal mechanism of cocaine-induced coronary and CNS ischemic toxicity (4, 7, 9–12).
Cocaine has substantial effects on cerebral blood flow, with a 25% to 30% reduction of global cerebral blood flow being shown experimentally in human cocaine users receiving a single 40-mg IV administered cocaine infusion (13, 14). Using MR angiography, cerebral vasospasm of large arteries has been shown in humans receiving 0.2 to 0.4 mg/kg IV-administered cocaine (15). These doses are modest compared with illicit cocaine use patterns; most chronic cocaine-dependent patients use an average of 3.5 g per week, but in some individuals, the dose can range up to 10 to 30 g per day (16, 17). In rats, exposure to chronic high doses of cocaine can result in capillary disruption (18).
Studies of cerebral perfusion conducted in asymptomatic cocaine-dependent participants without clinically apparent CNS symptoms have shown widespread and frequent (70–100%) perfusion defects (19–22). Such defects can be observed even after 6 months of verified abstinence (22). These perfusion studies evaluated mostly young cohorts (mean age, 25–32 years), and some MR imaging examinations failed to reveal structural lesions corresponding to the functional deficits (19, 22).
The prevalence of ischemic brain lesions in asymptomatic cocaine-dependent participants has not been investigated in controlled studies that evaluate a wide age range. Two case report series evaluating structural abnormalities in asymptomatic cocaine-dependent participants using MR imaging detected high-intensity focal brain lesions (23, 24). Approximately 25% to 60% of cocaine-abusing patients with acute strokes have ischemic infarcts (2, 4, 10, 25). Of the patients who present with ischemic symptoms, the majority (50–80%) have infarcts involving the middle cerebral artery (MCA) (2, 4, 10). They may be older on average than those presenting with hemorrhages (1, 6) and may more commonly become symptomatic after a delay with respect to when they last used cocaine (6, 10).
Impaired endothelium-dependent vasorelaxation in long-term cocaine users (12, 26), as well as the formation of longer half-life vasoactive metabolites of cocaine (8, 27, 28), may explain the delay in time from the last cocaine administration to the occurrence of ischemic symptoms (6, 8–10). This delay between cocaine use and ischemic symptoms, combined with the possibility that ischemic lesions may be located in areas of the brain (such as the cerebral white matter) that produce less severe or no apparent symptoms, reduce the likelihood that an individual will request medical attention. This raises the possibility that the relationship between cocaine use and ischemic stroke may be under-reported compared with hemorrhagic stroke (2) and may explain why some studies have not found an association between cocaine use and clinically apparent stroke (29).
MR imaging is superior to CT for detecting small ischemic changes (25, 30–33). Variability in identifying and quantifying high-intensity lesions (34) as well as the presence of risk factors (ie, age, hypertension, diabetes) for white matter hyperintensities in asymptomatic individuals (32) require the use of matched control samples (24). In the current study, we evaluated T2-weighted MR images to assess the incidence of severe hyperintense brain lesions across a wide age range of asymptomatic cocaine-dependent and normal control participants.
Methods
Participants
Cocaine-dependent participants were recruited from patients admitted to inpatient and outpatient treatment programs and research clinics of a metropolitan Department of Veterans Affairs Medical Center. The cocaine-dependent participants were 25- to 66-year-old men with histories of cocaine dependence longer than 1 year, current cocaine dependence diagnosis by Diagnostic and Statistical Manual of Mental Disorders-IV (DSM-IV) criteria (35), and self-reported use of at least $50/week, primarily by smoking. The cocaine-dependent group reported relatively chronic illness, with a mean length of exposure to cocaine of 10.8 years (SD = 5.7 years; range, 1–30 years). Of the 62 cocaine-dependent participants, 53 (85%) were African-American, seven (11%) were Caucasian, and two (3%) were of other races.
Cocaine-dependent participants were excluded if they had other psychiatric disorders of such severity as to require the use of pharmacotherapy; met DSM-IV criteria for dependence to opiates, benzodiazepines, or other sedative-hypnotics; or had a history of clinically significant medical conditions that are also likely to result in structural brain abnormalities (stroke, transient ischemic attack, cerebral infection, hypertension, diabetes, head trauma resulting in loss of consciousness of greater than 15 minutes). The final cocaine-dependent sample included 12 (19%) participants with current alcohol dependence, 16 (26%) with histories (more than 2 years ago) of alcohol dependence, and three (5%) with past amphetamine dependence.
Male control participants were recruited from community volunteers and ranged in age from 25 to 80 years. Older control participants, whose ages were beyond the oldest cocaine-dependent participants, were included to compare the age-related patterns of hyperintensity incidence in the two groups. Of the 116 control participants, 14 (12%) were African-American, 83 (72%) were Caucasian, and 19 (16%) were of other races. Exclusion criteria for the control participants were the same as those for the cocaine-dependent group. In addition, the control participants did not have histories of significant psychopathology or substance dependence and no first-degree relatives diagnosed with a major psychiatric disorder.
The above criteria excluded 12 cocaine-dependent participants (six with hypertension, three with diabetes, and three with histories of brain trauma with loss of consciousness of 45 minutes to 6 days) and two normal control participants (history of brain trauma with loss of consciousness of 9 and 48 hours, respectively). Written informed consent was obtained from all participants after a complete description of the study.
MR Evaluation
Imaging Protocol
MR imaging was performed using a 1.5-T instrument with an imaging protocol consisting of three sequences. Coronal pilot spin-echo images (100/30/1 [TR/TE/excitations]) with 10-mm thickness were used to evaluate symmetrical positioning of the head. If a patient's head was noticeably tilted laterally, he was repositioned and a new coronal pilot image was acquired. The image was then used to align the acquisition grid of the subsequent sagittal images. Pilot sagittal images were obtained from a second spin-echo sequence (550/26/2) with a 5-mm thickness. To obtain a true mid-sagittal image, the middle section of this series was aligned on the coronal pilot. The remaining sagittal images enabled visualization of the entire brain and were used to position the subsequent axial sequence. A transverse dual spin-echo sequence (2500/20, 90/2) with a 256 × 192-view matrix and a 25-cm field of view was used to acquire the 3-mm-thick contiguous axial images used for the ratings of hyperintensity.
MR Ratings
The images were rated visually for hyperintense lesions by an experienced radiologist with training in neuroradiology (D.B.H.), who was blinded to the subjects' clinical data. Separate ratings of the severity of hyperintensities were obtained for subcortical gray and white matter regions. Based on previous MR studies (24, 36), three regions were selected to be rated: cerebral white matter, subcortical gray matter (basal ganglia and thalamus region), and insular subcortex white matter. Representative images of hyperintense lesions exemplifying the three grades of severity are depicted in Figure 1.
The rater selected abnormal foci and avoided including expected hyperintensities, such as those produced by partial volume effects of sulcal CSF or uniform round cortical vessels appearing in typically anticipated positions within sulci. Only hyperintensities identified on both early and late echo images were considered in the rating, which was based on intensity, size, and confluence of lesions.
The absence of hyperintensities in a particular brain region was rated as zero. A rating of 1 involved minimal changes, which are rarely mentioned in radiologic reports because they are generally deemed to be of no significance. A rating of 2 was defined as definite brain tissue changes of mild severity and of questionable significance. Moderate to severe changes, thought to be significant indicators of a possible pathologic process, received a rating of 3. In asymptomatic older normal individuals, low-grade hyperintensities (ratings of 1 and 2) have not been correlated with cognitive or blood flow changes whereas lacunae (rating of 3) were associated with these changes (37, 38). Therefore, the data were analyzed using the severity ratings of 3 only. Representative images of cerebral and insular subcortex white matter lesions from images receiving a rating of 3 are shown in Figures 2 and 3.
To assess inter-rater reliability, the severity of the hyperintensities in a subset of 59 images was independently rerated by the MR researcher (G.B.). Inter-rater reliability coefficients (intraclass r) were highly statistically significant (P < .0001) for the hyperintensity severity ratings of the three regions and the summary composite variable: (rxx = .94, F = 30.6) for cerebral white matter, (rxx =.91, F = 20.2) for insular subcortex white matter, (rxx = .89, F = 17.8) for subcortical gray matter, and (rxx = .94, F = 34.8) for the composite score of the two white matter regions.
Data Analyses
The rates of occurrence of severe lesions (radiologist's rating of 3) among cocaine-dependent and normal participants were compared in multiple logistic regression analyses (SAS Proc CATMOD). The models included age, diagnosis, and their interaction. These were calculated in three separate regions (cortical white matter, insular subcortex white matter, and subcortical gray matter). A summary composite variable was also defined as an indicator of severe lesions in either of the two white matter regions. Odds ratios were computed to describe the strength of association between diagnosis and pathologic lesions (these estimates were computed at age 50 years, approximately the mean age of the sample). Follow-up multiple logistic regression analyses were conducted to evaluate the effects of race and years of drug-using experience (within the cocaine-dependent sample). Race was coded as a dichotomy (African-American versus non-African-American). The impact of race on the results was investigated because, despite the exclusion of participants with diagnosed hypertension, African-Americans have been reported to have higher blood pressure than non-African-Americans and hypertension may contribute to cerebrovascular disease (29). To analyze years of drug-using experience, normal participants were coded zero. Because the diagnostic group was also included in the statistical model, this statistical device yields regression estimates for that variable equivalent to what would be obtained if the cocaine-dependent group were analyzed separately.
Results
In the white matter region of the insula subcortex, the interaction of age by diagnosis was statistically significant (χ2 = 4.26, df = 1, P = .039), indicating that the nature of the relationship between increasing age and risk of lesion was not the same in the two samples. As shown in Figure 4, the risk of lesions in this region increased with age in the cocaine-dependent sample but remained essentially absent among normal individuals through the entire age range studied. Estimated at age 50 years, the probability of a lesion being present in this region was 20.3 times greater among cocaine-dependent participants (χ2 = 12.11, df = 1, P = .0005).
In the cerebral white matter, only the diagnosis had a significant effect (χ2 = 5.1, df = 1, P = .024). Figure 5 illustrates that the relationship between age and risk of lesion among control participants is similar in shape to that of cocaine-dependent participants, but equivalent risk is seen among cocaine-dependent participants approximately 20 years earlier (odds ratio = 16.7).
The analysis of the composite variable based on lesion in either region yielded the most significant diagnostic group differences (χ2 = 14.5, df = 1, P = .0001, odds ratio = 20.7). The apparent difference in shape of these functions displayed in Figure 6 did not reach statistical significance (interaction χ2 = 2.15, df = 1, P = .14). In the subcortical gray matter, no effects were statistically significant (all, P > .7). The addition of the indicators, race and years of cocaine use, did not alter these results. Neither of those variables was significantly related to risk of lesion in any area.
Finally, two of the older control participants (age 68 and 79 years, respectively) had small cortical infarcts but did not show evidence of lesions with severity ratings of 3 in either white matter regions. None of the cocaine-dependent participants had evidence of cortical infarcts.
Discussion
The MR data suggest that cocaine-dependent participants without clinically apparent cerebrovascular symptoms have an increased risk of white matter damage when compared with age-matched normal control participants. The increased frequency of lesions was strongly age-related and limited to white matter regions. The cerebral hemispheres and insula white matter lesion distribution is consistent with reports that the majority (50–80%) of cocaine-dependent patients presenting with infarctions had MCA involvement (2, 4, 10). Almost all of the lesions appeared hyperintense on the T2-weighted images, consistent with the premise that transient occlusion of arteries in the territory of the MCA can cause incomplete infarction that usually does not progress to frank cavitation and appear as hyperintensities (39, 40). In the absence of pathologic or angiographic proof, however, other mechanisms causing such lesions cannot be ruled out.
In this asymptomatic cocaine-dependent population, no cortical lesions were noted. Almost all lesions occurred in the territories supplied by either the medullary arteries (vessels that perforate the cortex and extend toward the lateral ventricles) or the perforating (lenticulostriate) arteries of the MCA (39, 41). These arteries usually have singular territories and do not anastomose even when (as in the case of the insula and its subcortical white matter) multiple branches of the MCA supply the region (39, 41–43). Although the multiple source arrangement of the insula region may offer some protection from hypotension (42), it clearly offers no protection from the effects of cocaine, as shown by the fact that insula lesions were observed almost exclusively in cocaine-dependent participants. This observation lends support to vasoconstriction of individual arteries as a possible mechanism underlying the lesions.
Cocaine's very short (40–50 minutes) plasma half-life can, in large part, be attributed to its immediate redistribution into tissues, particularly in the human brain (44), which poses no barrier to this lipophilic molecule (45). With its short half-life, the vasoconstrictive properties of cocaine cannot readily explain the cerebrovascular symptoms that occur hours to days after use (6, 8–10). In vivo, benzoylecgonine (BE), the primary pharmacologically active metabolite of cocaine, has a 6-hour half-life (44, 46, 47) and is a potent neurotoxin, causing agitation, seizures, and vasoconstriction (8, 48–51). Unlike cocaine, the uptake of BE into the brain is very low (52), but butyrylcholine esterase, the enzyme that catalyzes the metabolism of cocaine to BE, is abundantly present in cerebral white matter (30, 46, 53–55) as well as in plasma and in the liver. Because of its long half-life, BE may accumulate in brain tissue in higher concentrations than cocaine (45), resulting in a similar if not greater level of neurotoxicity (27), and it could trigger vasoconstriction, resulting in hyperintensities (8). In addition, elevated BE levels deep in the white matter (beyond the muscular arteriole level) may be neurotoxic through other (non-vasoconstrictive) mechanisms such as direct toxicity to brain cells or the vascular endothelium (18, 42).
Why increased rates of hyperintensities are observed only in the white matter regions of the cerebrum and insula, but not in the gray matter region of the basal ganglia and thalamus, is unknown. One possibility is that the enzymatic metabolism of cocaine to BE by butyrylcholine esterase may place white matter regions, where high enzyme activity is found in oligodendroglial cells, at especially high risk for vasoconstriction. Even though brain white matter has significantly higher levels of butyrylcholine esterase than cortical gray matter (56–59), subcortical gray matter structures have also been reported to have substantial levels of butyrylcholine esterase; however, enzyme activity in the subcortical gray matter is observed in neurons (56). Another possible explanation for the apparent differential susceptibility of white matter to develop hyperintensities involves our participant selection. For example, hyperintensities in the subcortical gray matter/internal capsule regions may be more likely to result in noticeable symptoms (60) and more likely to develop into intraparenchymal hemorrhages, which are most often symptomatic (4, 5, 25). Thus, many cocaine-dependent individuals with subcortical gray matter region hyperintensities would not be present in the current sample of asymptomatic participants.
Another important observation was the striking age-related pattern of the increase in white matter lesions, which was not explained by the number of years of cocaine use. In animal models, experimental transient MCA occlusion causes damage limited to the lateral aspect of the striatum (61, 62) and insula (63). Such transient occlusion has been shown to result in age-related deficits in locomotion and passive avoidance as well as altered pharmacologic responses to dopaminergic agents (61, 62). These studies support the possibility that cocaine-dependent patients who suffer from severe lesions in the MCA territory may have subtle neurocognitive deficits (22, 64–66). Individuals with these subtle deficits may not respond to treatment or be less likely to quit cocaine use or both and could therefore be over-represented in the older cocaine-dependent population.
The current cross-sectional study cannot readily answer questions relating to differential age-related sample attrition. To address such issues, prospective studies are needed. Several additional limitations of the study must be acknowledged. First, meaningful data regarding female addicts were not available, and the results cannot be generalized to female cocaine-dependent patients. Second, there is no certainty that the increased hyperintensities are related to cocaine use alone. For example, cocaine is sometimes “cut” with amphetamines and is often used in conjunction with other drugs of abuse, such as alcohol, producing other toxic metabolites, such as cocaethylene. Even diet, lifestyle, race, higher rates of tobacco dependence, and past IV drug use in the cocaine-dependent participants, or subtle differences in blood pressure, may have synergistically contributed to the observed differences in hyperintensities. Third, because the extent of drug abuse in the control group was documented by history alone, it is possible that their drug use was more extensive than reported. To the extent that this level of drug abuse would have resulted in an increase of hyperintensities in the control group, it would also have reduced the significance of the differences between the two groups.
Finally, it is possible that in this cross-sectional sample, the age-related increase in hyperintensities in the cocaine-dependent sample may be an underestimate because of differential mortality. Sudden, unexpected death resulting from cocaine use in young, otherwise healthy individuals occurs in an idiosyncratic manner and is commonly thought to be arrhythmogenic in nature, although the exact mechanism of death is rarely documented (67). Cocaine-related sudden death is a significant cause of mortality among young adults (68, 69), and in those who use cocaine and alcohol concomitantly, risk of sudden death is especially increased (16). Cardiac mortality is the most common cause of death in stroke patients and is associated with an annual cardiac mortality of 5% to 10% (70, 71). The insula region is involved in human heart rate regulation, and its damage may encourage a proarrhythmic state (72). Thus, if the kind of insular subcortex white matter lesions we observed in the cocaine-dependent population increases risk of sudden death, the frequency of the subinsular lesions we detected may be an underestimation because of selective mortality.
These findings have several important possible implications. If the possibility that premature appearance of severe white matter lesions may be associated with drug use was mentioned in the differential-diagnosis section of radiologic reports, it could help referring physicians to address the issue of covert cocaine use and its life-threatening risks with their patients better. As the cocaine-dependent population ages, an accelerated rate of white matter disease may have important epidemiologic implications. For example, the rate of dementia may increase as a result of the epidemic of crack cocaine use, which began in the mid-1980s (73, 74). Finally, the presence of white matter lesions in cocaine-dependent patients may affect their prognosis. Even though the relationship of hyperintensities to treatment outcome is unknown, it is possible that medications that prevent or ameliorate the vascular/perfusion effects of cocaine may be useful in the treatment of certain subgroups of cocaine-dependent patients.
Conclusion
The MR data suggest that cocaine-dependent participants without clinically apparent cerebrovascular symptoms have an increased frequency of severe T2 hyperintense lesions. The incidence of these lesions is strongly age-related and limited to the cerebral and insular subcortex white matter regions.
Acknowledgments
This work was supported by the Medication Development Division of the National Institute on Drug Abuse (1YO1 DA 50038), Research Grant AG-11595 from the National Institute of Aging, the Research and Psychiatry Services of the Department of Veterans Affairs, and the Marie Wilson Howells Endowment. The authors thank Sun Sook Hwang for data management and statistical support, Marguerite Callinan and Ewa Witt for coordinating the study, Yolanda Yamat for technical assistance, and Jeffrey Cummings, MD, for reviewing the manuscript.
Footnotes
1 The data herein were presented in part at the 149th Annual Meeting of the American Psychiatric Association, New York, 1996.
↵2 Address reprint requests to George Bartzokis, MD, North Little Rock VA Medical Center (116A/NLR), 2200 Fort Roots Drive, Building 170, North Little Rock, AR 72114.
References
- Received August 14, 1998.
- Accepted after revision April 6, 1999.
- Copyright © American Society of Neuroradiology